Arca Biopharma reported $1.74M in Selling and Administration Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US USD 1.29B 40M
Arca Biopharma ABIO:US USD 1.74M 513K
Biogen BIIB:US USD 563.3M 9.3M
Brainstorm Cell Therapeutics BCLI:US USD 3.06M 587K
Bristol Myers Squibb BMY:US USD 1.93B 147M
Capricor Therapeutics CAPR:US USD 2.56M 208.29K
Cytokinetics CYTK:US USD 48.22M 5.51M
Cytrx CYTR:US USD 51.91K 1.93M
Daiichi Sankyo 4568:JP JPY 113.49B 17.11B
Gilead Sciences GILD:US USD 1.21B 144M
GlaxoSmithKline GSK:LN GBP 1.97B 13M
Laboratory Of America LH:US USD 510M 24M
Myriad Genetics MYGN:US USD 130.5M 3.4M
Otsuka Holdings 4578:JP JPY 183.93B 972M
Pfizer PFE:US USD 3.54B 345M
United Therapeutics UTHR:US USD 98.4M 43.1M